TEL AVIV, Israel & ZURICH & NEW YORK–(BUSINESS WIRE)—- $SHLT–SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (“SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that Litchfield Hills Research, a leading equity research firm has initiated coverage of with a ‘Buy’ rating and an $11.00 price target. This price target represents a significant premium over the company’s current share price, highlighting the firm’s confidence in S
Business Wire Stock Sale/Buyback News
